Status:

COMPLETED

The DECRA Trial: Early Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury

Lead Sponsor:

National Trauma Research Institute

Collaborating Sponsors:

National Health and Medical Research Council, Australia

Victorian Trauma Foundation

Conditions:

Brain Injuries

Eligibility:

All Genders

15-60 years

Phase:

PHASE3

Brief Summary

This is a multi-centre randomised trial to evaluate the effect of early decompressive craniectomy on neurological function in patients with severe traumatic brain injury. The primary outcome is neuro...

Detailed Description

Comparison After meeting the entry criteria, and the patient will be randomised to either early DC surgery (see below) or best current conventional management. Those randomised to surgery will have th...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Age 15 - 60 years and within the first 72 hrs from time of injury
  • Severe diffuse Traumatic Brain Injury defined as:
  • GCS \< 9 and CT scan\* with any evidence of brain swelling CT brain scan (DII + some evidence of swelling or DIII or DIV) OR
  • GCS \>8 before intubation and DIII or DIV CT brain scan (basal cistern compression ± midline shift)
  • ICP monitor in situ. EVD recommended.
  • "Refractory ICP" despite best conventional management. Refractory ICP in this study will be defined as the spontaneous persistent increase in ICP despite optimal conventional ICU therapies (including intermittent EVD venting) of \>20mm Hg for more than 15 mins (continuously or cumulative over one hour).
  • Exclusion criteria:
  • Intracranial haemorrhage \> 3 cm diameter
  • Intracranial mixed haemorrhagic contusion \>5cm in long axis
  • Previous craniectomy
  • EDH/SDH/ or large contusion requiring evacuation
  • EDH/SDH \>0.5 cm thickness
  • Spinal cord injury
  • Penetrating brain injury
  • Arrest at scene
  • Unreactive pupils \>4mm, and GCS=3
  • Neurosurgery contraindicated (eg: severe coagulopathy)
  • No chance of survival after consideration of CT and clinical findings following Neurosurgical consultant assessment (eg hemispheric infarct after carotid dissection).

Exclusion

    Key Trial Info

    Start Date :

    August 1 2003

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2010

    Estimated Enrollment :

    155 Patients enrolled

    Trial Details

    Trial ID

    NCT00155987

    Start Date

    August 1 2003

    End Date

    December 1 2010

    Last Update

    September 10 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    The Alfred Hospital

    Melbourne, Victoria, Australia, 3004